Genprex to Present at The MicroCap Conference – PR Newswire (press release)

PR Newswire (press release)
AUSTIN, Texas, April 6, 2018 /PRNewswire/ — Genprex, Inc. (NASDAQ: GNPX), a clinical stage gene therapy company developing immunogene therapy for non-small cell lung cancer, announced today that Rodney Varner, Chairman and CEO, will present at The
First Choice Healthcare Solutions to Present at The MicroCap Conference on April 9thUptick Newswire (press release)
nFusz CEO to Present at The MicroCap Conference on April 9th and 10th in New York City at Essex HouseGlobeNewswire (press release)

all 4 news articles

…read more

Source:: MicroCap Stock News From Google News

Leave a Comment